Your browser doesn't support javascript.
loading
Structural insights into ligand recognition and selectivity of somatostatin receptors.
Zhao, Wenli; Han, Shuo; Qiu, Na; Feng, Wenbo; Lu, Mengjie; Zhang, Wenru; Wang, Mu; Zhou, Qingtong; Chen, Shutian; Xu, Wei; Du, Juan; Chu, Xiaojing; Yi, Cuiying; Dai, Antao; Hu, Liaoyuan; Shen, Michelle Y; Sun, Yaping; Zhang, Qing; Ma, Yingli; Zhong, Wenge; Yang, Dehua; Wang, Ming-Wei; Wu, Beili; Zhao, Qiang.
Afiliação
  • Zhao W; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Han S; University of Chinese Academy of Sciences, Beijing, China.
  • Qiu N; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Feng W; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, Zhejiang, China.
  • Lu M; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Zhang W; University of Chinese Academy of Sciences, Beijing, China.
  • Wang M; Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Zhou Q; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Chen S; University of Chinese Academy of Sciences, Beijing, China.
  • Xu W; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Du J; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Chu X; School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
  • Yi C; Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Dai A; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Hu L; University of Chinese Academy of Sciences, Beijing, China.
  • Shen MY; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Sun Y; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang Q; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Ma Y; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, UCAS, Hangzhou, Zhejiang, China.
  • Zhong W; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Yang D; State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Wang MW; The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Wu B; Amgen Asia R&D Center, Shanghai, China.
  • Zhao Q; Amgen Asia R&D Center, Shanghai, China.
Cell Res ; 32(8): 761-772, 2022 08.
Article em En | MEDLINE | ID: mdl-35739238
ABSTRACT
Somatostatin receptors (SSTRs) play versatile roles in inhibiting the secretion of multiple hormones such as growth hormone and thyroid-stimulating hormone, and thus are considered as targets for treating multiple tumors. Despite great progress made in therapeutic development against this diverse receptor family, drugs that target SSTRs still show limited efficacy with preferential binding affinity and conspicuous side-effects. Here, we report five structures of SSTR2 and SSTR4 in different states, including two crystal structures of SSTR2 in complex with a selective peptide antagonist and a non-peptide agonist, respectively, a cryo-electron microscopy (cryo-EM) structure of Gi1-bound SSTR2 in the presence of the endogenous ligand SST-14, as well as two cryo-EM structures of Gi1-bound SSTR4 in complex with SST-14 and a small-molecule agonist J-2156, respectively. By comparison of the SSTR structures in different states, molecular mechanisms of agonism and antagonism were illustrated. Together with computational and functional analyses, the key determinants responsible for ligand recognition and selectivity of different SSTR subtypes and multiform binding modes of peptide and non-peptide ligands were identified. Insights gained in this study will help uncover ligand selectivity of various SSTRs and accelerate the development of new molecules with better efficacy by targeting SSTRs.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Somatostatina / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Somatostatina / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article